| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.75M | - | |
| Dir | 164.0K | $12.45M | -8,000 | |
| VP | 100.3K | $7.61M | - | |
| VP | 83.3K | $6.32M | -60,846 | |
| CFO | 82.7K | $6.27M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28, 2023 | Swayze Eric63 | EVP Research | Sale+OE | 27,100 | $50.19 | $1,360,081.25 | -45.5% | -11.6% | -28.9% | |
| Dec 28, 2023 | Parshall B Lynne74 | Director | Sale+OE | 117,638 | $50.48 | $5,938,128.76 | -32.2% | -11.6% | -28.9% | |
| Dec 26, 2023 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 20,825 | $51.46 | $1,071,716.98 | -34.0% | -14.4% | -29.2% | |
| Dec 26, 2023 | Schneider Eugene64 | EVP, Chf Clinical Develop Ofcr | Sale+OE | 25,000 | $51.46 | $1,286,575.00 | -40.9% | -14.4% | -29.2% | |
| Dec 21, 2023 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sale+OE | 22,613 | $49.39 | $1,116,854.48 | -14.7% | -12.9% | -27.4% | |
| Dec 21, 2023 | Monia Brett P60 | Chief Executive Officer | Sale+OE | 24,000 | $49.38 | $1,185,219.85 | -9.2% | -12.9% | -27.4% | |
| Dec 21, 2023 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 10,612 | $49.50 | $525,323.99 | -6.8% | -12.9% | -27.4% | |
| Dec 14, 2023 | Monia Brett P60 | Chief Executive Officer | Sale+OE | 24,000 | $49.58 | $1,190,018.82 | -9.2% | -13.4% | -26.5% | |
| Dec 14, 2023 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 10,613 | $49.58 | $526,236.45 | -6.8% | -13.4% | -26.5% | |
| Dec 14, 2023 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sale+OE | 22,612 | $49.58 | $1,121,194.70 | -14.7% | -13.4% | -26.5% |